SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
REVENUE	$ 3,092,171		$ 1,103,516		$ 6,541,330	$ 4,173,542
COST OF REVENUE	(2,624,564)		(944,226)		(5,491,158)	(3,358,945)
GROSS PROFIT	467,607		159,290		1,050,172	814,597
OTHER INCOME	50,429		23,729		112,916	770,370
PROFIT BEFORE TAX	136,542		(35,354)		475,286	1,035,150
Tax expense	108,280		487		108,280	1,347
Net profit	$ 28,262	$ 338,744	$ (35,841)	$ 1,069,644	367,006	1,033,803
TOTAL [Member]
REVENUE					6,541,330	4,173,542
COST OF REVENUE					(5,491,158)	(3,358,945)
GROSS PROFIT					1,050,172	814,597
OTHER INCOME					112,916	770,370
General and administrative					(680,265)	(545,411)
FINANCE COSTS					(6,837)	(4,406)
PROFIT BEFORE TAX					475,286	1,035,150
Tax expense					(108,280)	(1,347)
Net profit					367,006	1,033,803
BGLC [Member]
REVENUE					0	0
COST OF REVENUE					0	0
GROSS PROFIT					0	0
OTHER INCOME					0	7
General and administrative					(80,218)	(48,413)
FINANCE COSTS					0	0
PROFIT BEFORE TAX					(80,218)	(48,406)
Tax expense					0	0
Net profit					(80,218)	(48,406)
Chemrex [Member]
REVENUE					6,075,860	4,167,001
COST OF REVENUE					(5,132,630)	(3,328,637)
GROSS PROFIT					943,230	838,364
OTHER INCOME					109,068	762,718
General and administrative					(556,619)	(449,744)
FINANCE COSTS					(4,534)	(3,045)
PROFIT BEFORE TAX					491,145	1,148,293
Tax expense					(107,626)	0
Net profit					383,519	1,148,293
BioNexus Malaysia [Member]
REVENUE					465,470	6,541
COST OF REVENUE					(358,528)	(30,308)
GROSS PROFIT					106,942	(23,767)
OTHER INCOME					3,848	7,645
General and administrative					(44,128)	(47,254)
FINANCE COSTS					(2,303)	(1,361)
PROFIT BEFORE TAX					64,359	(64,737)
Tax expense					(654)	(1,347)
Net profit					$ 63,705	$ (66,084)